In vitro correlates of HIV-2-mediated HIV-1 protection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 12, 2000, Pages 6797-6802

  Kokkotou, Efi G ^a   Sankalé, Jean Louis ^a   Mani, Indu ^a   Guèye Ndiaye, Aissatou ^b   Schwartz, David ^c   Essex, Myron E ^a   Mboup, Souleymane ^b   Kanki, Phyllis J ^a  

^a Harvard AIDS Institute   (United States)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFECTION SENSITIVITY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PROSTITUTION; SEQUENCE HOMOLOGY; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; CHEMOKINES, CC; FEMALE; HIV-1; HIV-2; HUMANS; PROSPECTIVE STUDIES; RECEPTORS, CCR5;

EID: 0034612221     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.97.12.6797     Document Type: Article

References (48)